CD4+ Acute Undifferentiated Leukaemia, Probably Early Monoblastic Type, Developing in a Patient with Myelodysplastic Syndrome and Bone Marrow Fibrosis

References

• Sultan C., Sigaux F., Imbert M., Reyes F. Acute myelodysplasia with myelofibrosis: a report of eight cases. British Journal of Haematology 1981; 49: 11–16
   PubMed Web of Science ®Google Scholar
• Weisenburger D.D. Acute myelofibrosis terminating as acute myeloblastic leukemia. American Journal of Clinical Pathology 1989; 73: 128–134
   Google Scholar
• Vallepsi T., Tomabadella M., Julia A. Myelodysplastic syndromes: A study of 101 cases according to FAB classification. British Journal of Haematotlogy 1985; 61: 83–92
   PubMed Web of Science ®Google Scholar
• Scheeder M.T., Prchal J.T., Parmley R.T., Carrole A.J., Gewirtz A.M., Hoffman R. An acute myelopro-liferative disorder characterized by myelofibrosis and blast cells that express phenotype properties associated with multiple hematopoietic lineages. American Journal of Clinical Pathology 1985; 83: 114–120
   PubMed Web of Science ®Google Scholar
• Eridani S., Chan L.C., Halil O., et al. Acute biphenotypic leukaemia (myeloid and null-ALL type) supervining in a myelodysplastic syndrome. British Journal of Haematology 1985; 61: 525–529
   PubMed Web of Science ®Google Scholar
• Bauermeister D.E. Quantification of bone marrow reticulin—a normal range. American Journal of Clinical Pathology 1971; 56: 24–31
   PubMed Web of Science ®Google Scholar
• Ohyashiki K., Sasao I., Ohyashiki J.M., Murakami T., et al. Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis. Cancer 1991; 68: 178–183
   PubMed Web of Science ®Google Scholar
• Stasi R., Del Poeta G., Venditti A., Masi M., Stipa E., et al. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-MO). Blood 1994; 83: 1619–1625
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Kuramoto A. Effects of platelet-derived growth factor, epidermal growth factor, and transforming growth factor-b on the growth of human marrow fibroblasts. British journal of Haematology 1988; 69: 9–12
   PubMed Web of Science ®Google Scholar
• Tzang D.J., Denel T.F., Huang J.S., Baehner R.L. Platelet-derived growth factor promotes human peripheral monocyte activation. Blood 1985; 66: 179–183
   PubMed Web of Science ®Google Scholar
• Burstein S.A., Malpass T.W., Yee E., Kadin M., Bridgen M., Adamson J.M., Marker L.A. Platelet factor 4-excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. British Journal of Haematology 1984; 57: 383–392
   PubMed Web of Science ®Google Scholar
• Thiele J., Romatowski Ch., Wagner S., Dienemann D., Stein H., Fischer R. Macrophages in reactive-inflammatory lesions of the bone marrow and in MDS. Pathology Research and Practice 1992; 188: 995–1001
   PubMed Web of Science ®Google Scholar
• Wood G.S., Wagner N.L., Warnke R.A. Anti-Leu-3/T4 antibodies react with cells of monocyte/ macrophage/Langerhans lineage. Journal of Immunology 1983; 131: 212–216
   PubMed Web of Science ®Google Scholar
• Kaplan S.S., Penchansky L., Stolc V., Contis L., Krause J.R. Immunophenotyping in the classification of acute leukaemias in adults. Interpretation of multiple lineage reactivity. Cancer 1989; 63: 1520–1527
   PubMed Web of Science ®Google Scholar
• Neudorf S., DeLaat C., Jones M. Expression of CD4 molecule of acute non-lymphocytic leukemia cell lines. Journal of Clinical Laboratory Analysis 1989; 3: 312–315
   PubMed Web of Science ®Google Scholar
• Lombard E.H., Mansvelt E. P. G. CD4+, CD33-, CD13-, CD14- Acute monoblastic leukaemia. Acta Haematologica 1992; 87: 151–152
   PubMed Web of Science ®Google Scholar
• Szabo G., Miller C.L., Kodys K. Antigen presentation by the CD4 positive monocyte subset. Journal of Leukocytic Biology 1990; 47: 111–120
   PubMed Web of Science ®Google Scholar
• Old L.J. Tumour necrosis factor (TNF). Science 1985; 230: 630
   PubMed Web of Science ®Google Scholar
• Breard J., Reinharz E., Kung P., Goldstein G., Schlossman S. A monoclonal antibody reactive with peripheral blood monocytes. Journal of Immunology 1980; 124: 1943–1948
   PubMed Web of Science ®Google Scholar
• Bordessoule D., Jones M., Gatter K.C., Mason J. Immunohistochemical patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66, CD67. British Journal of Haematology 1993; 83: 370–383
   PubMed Web of Science ®Google Scholar
• Trezzini C., Jungi T., Spycher M., Muly F., Rao P. Human monocytes CD36 and CD16 are signalling molecules. Evidence for studies using antibody-induced chemiluminiscence as a tool to probe signal transduction. Immunology 1990; 71: 29–37
   PubMedGoogle Scholar
• Mittelman M., Karcher P., Kammerman L., Lessin L. High Ia (HLA-DR) and low CD11b (Mol) expression may predict early conversion to leukaemia in myelodysplastic syndromes. American Journal of Hematology 1993; 43: 165–171
   PubMed Web of Science ®Google Scholar
• Griffin J.D. The use of monoclonal antibodies in the characterisation of myeloid leukemias. Human Pathology 1987; 1: 81–91
   Google Scholar
• Steward S.J., Fujimoto J., Levy R.J. Human T lymphocytes and monocytes bear the same Leu3 (T4) antigen. Journal of Immunology 1986; 136: 3773–3778
   PubMed Web of Science ®Google Scholar
• Larson R.S., McCurley T.L., III. CD4 Predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry. American Journal of Clinical Pathology 1995; 104: 204–211
   PubMed Web of Science ®Google Scholar